Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 3.28% | 61.09 | 0.0% | $936.95m | |
| AMGN | Amgen, Inc. | -1.21% | 253.15 | 1.3% | $740.47m | |
| NVAX | Novavax, Inc. | 31.62% | 104.56 | 102.0% | $729.34m | |
| GILD | Gilead Sciences, Inc. | -0.44% | 76.42 | 1.0% | $691.31m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.17% | 640.88 | 2.5% | $676.66m | |
| BIIB | Biogen, Inc. | -0.54% | 268.35 | 1.6% | $574.95m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.66% | 299.06 | 1.9% | $525.02m | |
| ILMN | Illumina, Inc. | -1.92% | 372.12 | 3.5% | $298.87m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.98% | 112.46 | 2.0% | $233.18m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.21% | 127.98 | 4.3% | $217.91m | |
| SGEN | Seattle Genetics, Inc. | 3.34% | 176.14 | 6.1% | $205.38m | |
| SRNE | Sorrento Therapeutics, Inc. | 3.00% | 7.38 | 1.8% | $197.64m | |
| IMMU | Immunomedics, Inc. | 1.30% | 41.16 | 11.0% | $181.04m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.25% | 163.89 | 13.9% | $171.56m | |
| INCY | Incyte Corp. | 0.80% | 108.65 | 2.5% | $165.64m |
Company Profile
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.